Key result
Endothelial cell activation is a key pathogenetic event in pregnancy-induced hypertensive disorders, though causative factors remain unclear and low-dose aspirin prophylaxis lacks definitive conclusions.
Why the study?
Does low-dose aspirin prophylaxis improve outcomes in pregnant women at risk for pregnancy-induced hypertensive disorders?
Does low-dose aspirin prophylaxis improve outcomes in pregnant women at risk for pregnancy-induced hypertensive disorders?
There remains a lack of definitive evidence regarding the efficacy and safety of low-dose aspirin prophylaxis for pregnancy-induced hypertensive disorders.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wallenburg et al. (1994) conducted a review in Pregnancy-induced hypertensive disorders. Low-dose aspirin prophylaxis was evaluated. Endothelial cell activation is a key pathogenetic event in pregnancy-induced hypertensive disorders, though causative factors remain unclear and low-dose aspirin prophylaxis lacks definitive conclusions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: